|
Wyamycin EDrug - Wyamycin E The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL
Active Ingredient(s) -
Erythromycin Ethylsuccinate
Strength -
EQ 200MG BASE/5ML
Applicant -
WYETH AYERST
New Drug Application (NDA) Number -
062123
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Wyeth Ayerst Laboratories
Wyamycin E
Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral
Erythromycin Ethylsuccinate Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral Pediamycin Eq 200mg Base/5ml Suspension; Oral Pediamycin 400 Eq 400mg Base/5ml Suspension; Oral Wyamycin E Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 200mg Base/5ml Suspension; Oral Erythromycin Ethylsuccinate Eq 400mg Base/5ml Suspension; Oral NewDrugInformation |